Blood doping refers to the practice some professional athletes use to artificially raise their amount of red blood cells with repeat blood transfusions, and with higher levels of oxygen in their blood they can push the limits of human endurance.

U.S. Food and Drug Administration officials have approved Omontys ( peginesatide ), a drug administered through monthly injections to treat anemia in patients with chronic kidney disease.